Clinical Trials Logo

Stage I Testicular Seminoma clinical trials

View clinical trials related to Stage I Testicular Seminoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT05500391 Recruiting - Glioma Clinical Trials

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

SUR-CAN
Start date: February 28, 2024
Phase: Phase 2
Study type: Interventional

This is a multicenter, interventional, randomized study among adult patients recently diagnosed with a rare tumor (<12 months). The study will aim to compare compliance with the personalized post-treatment surveillance plan, established for each patient according to national guidelines, when the surveillance is conducted in person by a hospital-based physician (control arm) or remotely by a trained nurse (experimental arm).

NCT ID: NCT02537548 Active, not recruiting - Lymphadenopathy Clinical Trials

Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma

Start date: August 28, 2015
Phase: N/A
Study type: Interventional

This phase II trial studies how well retroperitoneal lymph node dissection (RPLND) works in treating patients with stage I-IIa testicular seminoma. The retroperitoneum is the space in the body behind the intestines that is typically the first place that seminoma spreads. RPLND is a surgery that removes lymph nodes in this area to treat testicular seminoma and may experience fewer long-term toxicities, such as a second cancer, cardiovascular disease, metabolic syndrome (pre-diabetes), or lung disease.